Zdrowie i gospodarka · 30/07/2013

FDA Releases Guidance on Safety Labeling Changes for Drug and Biological Products

The Food and Drug Administration (FDA) has announced the availability of a guidance document outlining the requirements for drug and biological product manufacturers to make safety-related labeling changes in response to new safety information, as mandated by the Food and Drug Administration Amendments Act of 2007 (FDAAA).